Sales and Marketing

Showing 15 posts of 11527 posts found.

TNF blockers must carry children’s cancer warning

August 7, 2009 Research and Development, Sales and Marketing FDA, RA, TNF

The FDA has ruled that TNF blocker drugs should carry new warnings of the increased risk of certain cancers for …

Vernalis and GSK sign risk-sharing deal

August 7, 2009 Research and Development, Sales and Marketing Deals, GSK, Vernalis

Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …

Pfizer agrees price cut in Clinton deal

August 7, 2009 Research and Development, Sales and Marketing HIV, Pfizer, generics

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

Hugh Grant backs social media healthcare site

August 7, 2009 Medical Communications, Sales and Marketing Digitial, patient information

The actor Hugh Grant is backing a new health advice website that encourages patients to share their experiences of illness. …

Vasella targeted by animal rights activists

August 6, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …

Afinitor approved in EU

August 6, 2009 Research and Development, Sales and Marketing Afinitor, Cancer, Europe, Novartis

Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …

US approval for Onglyza

August 6, 2009 Research and Development, Sales and Marketing AZ, BMA, diabetes

Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …

Industry working group to look at UK digital marketing

August 6, 2009 Medical Communications, Sales and Marketing digi, pm society

The PM Society has set up an industry working group to bring some much-needed clarity to the uncharted waters of …

Boehringer’s lung cancer candidate enters phase III

August 5, 2009 Research and Development, Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …

Centocor launches online arthritis talk show

August 4, 2009 Medical Communications, Sales and Marketing Centacor, RA, US, digi

An online talk show for rheumatoid arthritis patients has been launched in the US with the aim of raising awareness …

Avastin gets US approval in kidney cancer

August 4, 2009 Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …

Crestor drives positive results for AZ

July 31, 2009 Sales and Marketing AZ, Crestor

AstraZeneca delivered a solid second quarter performance thanks to US delays to generic rivals and strong Crestor sales. The results …

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009 Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …

Sanofi makes bold promises with Q2 results

July 30, 2009 Sales and Marketing Sanofi-Aventis, patents

Sanofi-Aventis has promised its 2013 sales will at least match those the company made last year, despite facing huge and …

BMS profits surge ahead

July 30, 2009 Sales and Marketing BMS

Bristol Myers-Squibb's earnings growth massively outstripped its income in the second quarter of the year. The company saw its net …
The Gateway to Local Adoption Series

Latest content